Tag Archives: HEADLINE | Inovio shares tumble as analysts say COVID-19 fax update leaves more questions than answers

Inovio Pharmaceuticals Inc. shares tumbled 22% Tuesday, a day after the company reported a broader-than-expected second-quarter loss and offered a limited update on its COVID-19 vaccine candidate that is currently in clinical trials. The stock INO, -22.88% is still up 343% year-on-year after winning early in the coronavirus pandemic in …

Inovio Pharmaceuticals Inc. shares tumbled 22% Tuesday, a day after the company reported a broader-than-expected second-quarter loss and offered a limited update on its COVID-19 vaccine candidate that is currently in clinical trials. The front INO is still up 343% year-on-year after winning early in the coronavirus pandemic in hopes …